Clinical implications of local renin-angiotensin-aldosterone systems Edward D. Frohlich Invited Commentary Pages: 247 - 248
Optimal medical management of angina Brian NoronhaEdward DuncanJonathan A. Byrne OriginalPaper Pages: 259 - 265
Acute coronary syndromes in patients with renal failure Peter A. McCullough OriginalPaper Pages: 266 - 270
B-type natriuretic peptide in ischemic heart disease Rajat DeoJames A. de Lemos OriginalPaper Pages: 271 - 277
ST-segment monitoring in patients with acute coronary syndromes Per JohansonGalen S. WagnerMitchell W. Krucoff OriginalPaper Pages: 278 - 283
Revised guidelines for the management of non-ST-segment elevation acute coronary syndromes Debabrata MukherjeeKim A. Eagle News Pages: 289 - 295
Acute coronary syndromes in patients with diabetes mellitus: Diagnosis, prognosis, and current management strategies Rhoda BrosnanL. Kristin Newby OriginalPaper Pages: 296 - 302
Dosing considerations and monitoring of low molecular weight heparins and glycoprotein IIb/IIIa antagonists in patients with renal insufficiency Chidambaram RammohanDan Fintel OriginalPaper Pages: 303 - 309
Emergency management of hemorrhagic complications in the era of glycoprotein IIb/IIIa receptor antagonists, clopidogrel, low molecular weight heparin, and third-generation fibrinolytic agents Walter S. SchroederPritesh J. Gandhi OriginalPaper Pages: 310 - 317
When to order cardiovascular magnetic resonance in adults with congenital heart disease Sonya V. Babu-NarayanPhilip J. KilnerMichael A. Gatzoulis News Pages: 324 - 330
Detecting and diagnosing arrhythmias in adults with congenital heart disease Kathryn K. CollinsAnne M. Dubin OriginalPaper Pages: 331 - 335